Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
Titel:
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
Auteur:
Le, Xiuning Eisert, Anna Hsia, Te-Chun Raut, Nirmal Vivek Ahmad, Azura Chan, Oscar Siu Hong De Bondt, Charlotte Farrugia, David Froesch, Patrizia González-Cao, Maria Hendriks, Lizza Hochmair, Maximillian J. Mazieres, Julien O'Sullivan, Hazel Popat, Sanjay Samol, Jens van der Wekken, Anthonie J. Yang, Tsung-Ying Tho, Lye Mun Himpe, Ulrike Lam, Wei-Sen Lee, Kirsty Wai Chung Petrini, Iacopo Berghoff, Karin Karachaliou, Niki Joshi, Kirti Vlassak, Soetkin Chang, Gee-Chen